These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 7714976

  • 1. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis.
    Cupp MR, Bostwick DG, Myers RP, Oesterling JE.
    J Urol; 1995 May; 153(5):1543-8. PubMed ID: 7714976
    [Abstract] [Full Text] [Related]

  • 2. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H.
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [Abstract] [Full Text] [Related]

  • 3. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M, Stamey TA, McNeal JE, Yemoto CM.
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [Abstract] [Full Text] [Related]

  • 4. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively?
    Rubin MA, Mucci NR, Manley S, Sanda M, Cushenberry E, Strawderman M, Montie JE, Bassily NH.
    J Urol; 2001 Jan; 165(1):114-8. PubMed ID: 11125378
    [Abstract] [Full Text] [Related]

  • 5. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L, Poulos CK, Pan CX, Jones TD, Daggy JK, Eble JN, Koch MO.
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [Abstract] [Full Text] [Related]

  • 6. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease.
    Miyake H, Sakai I, Harada K, Hara I, Eto H.
    Int J Urol; 2005 Mar; 12(3):270-4. PubMed ID: 15828954
    [Abstract] [Full Text] [Related]

  • 7. One core positive prostate biopsy is a poor predictor of cancer volume in the radical prostatectomy specimen.
    Wang X, Brannigan RE, Rademaker AW, McVary KT, Oyasu R.
    J Urol; 1997 Oct; 158(4):1431-5. PubMed ID: 9302137
    [Abstract] [Full Text] [Related]

  • 8. Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population?
    Anast JW, Andriole GL, Bismar TA, Yan Y, Humphrey PA.
    Urology; 2004 Sep; 64(3):544-50. PubMed ID: 15351590
    [Abstract] [Full Text] [Related]

  • 9. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens.
    Poulos CK, Daggy JK, Cheng L.
    Cancer; 2004 Aug 01; 101(3):527-32. PubMed ID: 15274065
    [Abstract] [Full Text] [Related]

  • 10. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS, Cookson MS, Coffey CS, Vader V, Roberts RL, Chang SS, Smith JA, Shappell SB.
    J Urol; 2002 Aug 01; 168(2):519-24. PubMed ID: 12131301
    [Abstract] [Full Text] [Related]

  • 11. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features.
    Boccon-Gibod LM, Dumonceau O, Toublanc M, Ravery V, Boccon-Gibod LA.
    Eur Urol; 2005 Dec 01; 48(6):895-9. PubMed ID: 16125298
    [Abstract] [Full Text] [Related]

  • 12. Combined prostate-specific antigen density and biopsy features to predict "clinically insignificant" prostate cancer.
    Loeb S, Roehl KA, Thaxton CS, Catalona WJ.
    Urology; 2008 Jul 01; 72(1):143-7. PubMed ID: 18436287
    [Abstract] [Full Text] [Related]

  • 13. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC.
    Cancer; 2003 Dec 01; 98(11):2344-50. PubMed ID: 14635068
    [Abstract] [Full Text] [Related]

  • 14. The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management.
    Ochiai A, Troncoso P, Chen ME, Lloreta J, Babaian RJ.
    J Urol; 2005 Dec 01; 174(6):2164-8, discussion 2168. PubMed ID: 16280756
    [Abstract] [Full Text] [Related]

  • 15. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR, McNeal JE, Gill H, Presti JC.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):386-91. PubMed ID: 15145152
    [Abstract] [Full Text] [Related]

  • 16. Prostate biopsy: who, how and when. An update.
    Djavan B, Milani S, Remzi M.
    Can J Urol; 2005 Feb 01; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [Abstract] [Full Text] [Related]

  • 17. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors.
    Grober ED, Tsihlias J, Jewett MA, Sweet JM, Evans AJ, Trachtenberg J, Robinette M, Nam RK.
    Can J Urol; 2004 Feb 01; 11(1):2157-62. PubMed ID: 15003158
    [Abstract] [Full Text] [Related]

  • 18. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT, Eroglu A, Sahin A, Zorlu F, Ozen H.
    Urol Oncol; 2007 Feb 01; 25(5):376-82. PubMed ID: 17826653
    [Abstract] [Full Text] [Related]

  • 19. Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.
    Epstein JI, Sanderson H, Carter HB, Scharfstein DO.
    Urology; 2005 Aug 01; 66(2):356-60. PubMed ID: 16040085
    [Abstract] [Full Text] [Related]

  • 20. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer.
    D'Amico AV, Wu Y, Chen MH, Nash M, Renshaw AA, Richie JP.
    J Urol; 2001 Jan 01; 165(1):126-9. PubMed ID: 11125380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.